StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

4,5-Dihydro-2-(methylthio)-1h-imidazole-1-carboxylic acid methyl ester → HCID 178501934, Verbindung

HRID 968774
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 968774
[NH2:1][C:2]1[CH:3]=[C:4]([C:12]#[N:13])[C:5]2[N:9]=[CH:8][NH:7][C:6]=2[C:10]=1[CH3:11].CS[C:16]1[N:17]([C:21]([O:23][CH3:24])=[O:22])[CH2:18][CH2:19][N:20]=1>>[CH3:24][O:23][C:21]([N:17]1[CH2:18][CH2:19][NH:20][C:16]1=[N:1][C:2]1[CH:3]=[C:4]([C:12]#[N:13])[C:5]2[NH:9][CH:8]=[N:7][C:6]=2[C:10]=1[CH3:11])=[O:22]
KomponentenVersuchsvorschriftQuellen und NachweiseNotizen zur Reaktion

Komponenten

3

Edukt 2

HCID 109429534,5-Dihydro-2-(methylthio)-1h-imidazole-1-carboxylic acid methyl ester2×HCID 178430523HCID 178430523, Verbindung2×

Produkt 1

HCID 178501934HCID 178501934, Verbindung

Versuchsvorschrift

There are many suitable methods for coupling intermediate (10) with side chain 4,5-Dihydro-2-(methylthio)-1H-imidazole-1-carboxylic Acid, Methyl Ester (29). Referring to General Scheme (4), intermediate (10) is coupled to side chain (29) to yield intermediate 2-(7-Cyano-4-methyl-1H-benzimidazol-5-yl-imino)-imidazolidine-1-carboxylic Acid Methyl Ester (30), and thereafter deprotected to yield product 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile (31a) as the preferred anhydrous, monoacetate salt (which can be further purified by recrystallization to yield final product (31b)). See Example 5. The assay described in Example 3 may be used to analyze products (31a) and (31b) for the level of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile that is present. In one embodiment, the preferred anhydrous monoacetate salt of 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile (31a) and (31b) that is produced is substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile. In one embodiment, the preferred anhydrous monoacetate salt of 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile (31a) and (31b) that is produced contains less than 70 ppb (parts per billion), preferably less than 15 ppb, more preferably less than 5 ppb, of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile. Other solvent systems that may be used to recrystallize product (31a) to yield final product (31b) include: ethanol/water, acetone/water, acetonitrile/water, tetrahydrofuran/water, methanol, N,N-dimethylacetamide, and acetonitrile. Although in General Scheme 4 intermediate (30) is carried forward without isolation, it may be isolated as shown in Example 16. Another method to attach the side chain includes Example 17. Still another suitable method is described in U.S. Pat. No. 6,066,740.

Quellen und Nachweise

ORD-Eintrag
ord-c5094c1d8eec4d6db6078d03b6e0841d
Quelldatensatz
uspto-grants-2007_12
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07304084B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftQuellen und NachweiseNotizen zur Reaktion